Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme strong>CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Citations de cet article :

Addressing circadian rhythm disturbances in depressed patients

RW Lam
Journal of Psychopharmacology 22 (7_suppl) 13 (2008)
DOI: 10.1177/0269881108092591
Voir cet article

On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal

Mark J. Millan
The International Journal of Neuropsychopharmacology 17 (07) 1009 (2014)
DOI: 10.1017/S1461145712001496
Voir cet article

Serotonin receptors involved in antidepressant effects

Francesc Artigas
Pharmacology & Therapeutics 137 (1) 119 (2013)
DOI: 10.1016/j.pharmthera.2012.09.006
Voir cet article

An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy

Mark J. Millan
Neuropharmacology 68 2 (2013)
DOI: 10.1016/j.neuropharm.2012.11.015
Voir cet article

The anxiogenic-like effects of dehydration in a semi-desert rodent Meriones shawi indicating the possible involvement of the serotoninergic system

Abdeljalil Elgot, Omar El hiba and Halima Gamrani
Acta Histochemica 114 (6) 603 (2012)
DOI: 10.1016/j.acthis.2011.11.005
Voir cet article

Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats

Philippe De Deurwaerdère, Marta Ramos, Rahul Bharatiya, et al.
Neuropharmacology 166 107915 (2020)
DOI: 10.1016/j.neuropharm.2019.107915
Voir cet article

Stress-protective neural circuits: not all roads lead through the prefrontal cortex

John P. Christianson and Benjamin N. Greenwood
Stress 17 (1) 1 (2014)
DOI: 10.3109/10253890.2013.794450
Voir cet article

5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment

Raymond Mongeau, Cédric B. P. Martin, Caroline Chevarin, et al.
Journal of Neurochemistry 115 (2) 438 (2010)
DOI: 10.1111/j.1471-4159.2010.06932.x
Voir cet article

5-HT2 ligands in the treatment of anxiety and depression

Gaël Quesseveur, Hai T Nguyen, Alain M Gardier and Bruno P Guiard
Expert Opinion on Investigational Drugs 21 (11) 1701 (2012)
DOI: 10.1517/13543784.2012.719872
Voir cet article

Iloperidone, asenapine and lurasidone: a primer on their current status

Frank I Tarazi and Stephen M Stahl
Expert Opinion on Pharmacotherapy 13 (13) 1911 (2012)
DOI: 10.1517/14656566.2012.712114
Voir cet article

The mechanism, efficacy, and tolerability profile of agomelatine

Sarah E MacIsaac, André F Carvalho, Danielle S Cha, Rodrigo B Mansur and Roger S McIntyre
Expert Opinion on Pharmacotherapy 15 (2) 259 (2014)
DOI: 10.1517/14656566.2014.862233
Voir cet article

The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors

Mark J. Millan, Philippe Marin, Maud Kamal, et al.
The International Journal of Neuropsychopharmacology 14 (06) 768 (2011)
DOI: 10.1017/S1461145710001045
Voir cet article

Pharmacologic Rescue of Motivational Deficit in an Animal Model of the Negative Symptoms of Schizophrenia

Eleanor H. Simpson, Christoph Kellendonk, Ryan D. Ward, et al.
Biological Psychiatry 69 (10) 928 (2011)
DOI: 10.1016/j.biopsych.2011.01.012
Voir cet article

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

Mark J. Millan
Neurotherapeutics 6 (1) 53 (2009)
DOI: 10.1016/j.nurt.2008.10.039
Voir cet article

Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration

Raffaella Molteni, Francesca Calabrese, Sara Pisoni, et al.
The World Journal of Biological Psychiatry 11 (2) 148 (2010)
DOI: 10.3109/15622970903447659
Voir cet article

Serotonin 2c receptor RNA editing in major depression and suicide

Rebecca Lyddon, Andrew J. Dwork, Mehdi Keddache, Larry J. Siever and Stella Dracheva
The World Journal of Biological Psychiatry 14 (8) 590 (2013)
DOI: 10.3109/15622975.2011.630406
Voir cet article

5-HT6 pharmacology inconsistencies

Franco Borsini, Fabio Bordi and Teresa Riccioni
Pharmacology Biochemistry and Behavior 98 (2) 169 (2011)
DOI: 10.1016/j.pbb.2010.12.021
Voir cet article

In vivo Effect of Antidepressants on [3H]paroxetine Binding to Serotonin Transporters in Rat Brain

Subhash M. Nadgir and Manish Malviya
Neurochemical Research 33 (11) 2250 (2008)
DOI: 10.1007/s11064-008-9703-z
Voir cet article

Multimodal serotonergic antidepressants

D. S. Danilov
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117 (9) 103 (2017)
DOI: 10.17116/jnevro201711791103-111
Voir cet article

The Neurotensin NTS1 Receptor Agonist PD149163 Produces Antidepressant-Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant Drugs

Lawrence M. Carey, Remington J. Rice and Adam J. Prus
Drug Development Research 78 (5) 196 (2017)
DOI: 10.1002/ddr.21393
Voir cet article

Extremely Randomized Machine Learning Methods for Compound Activity Prediction

Wojciech Czarnecki, Sabina Podlewska and Andrzej Bojarski
Molecules 20 (11) 20107 (2015)
DOI: 10.3390/molecules201119679
Voir cet article

Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2

Minati Singh, M. Bridget Zimmerman, Terry G. Beltz and Alan Kim Johnson
Physiology & Behavior 97 (3-4) 446 (2009)
DOI: 10.1016/j.physbeh.2009.03.029
Voir cet article

Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT2 agonists in the rat basal ganglia

S. Navailles, M. Lagière, C. Le Moine and P. De Deurwaerdère
Experimental Brain Research 230 (4) 525 (2013)
DOI: 10.1007/s00221-013-3562-9
Voir cet article

Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression

Ying-Hui Wu, Jeanine Ursinus, Jiang-Ning Zhou, et al.
Journal of Affective Disorders 148 (2-3) 357 (2013)
DOI: 10.1016/j.jad.2012.12.025
Voir cet article

Biological rhythms and melatonin in mood disorders and their treatments

Laurence Lanfumey, Raymond Mongeau and Michel Hamon
Pharmacology & Therapeutics 138 (2) 176 (2013)
DOI: 10.1016/j.pharmthera.2013.01.005
Voir cet article

Determination of Novel Synthetic 5HT2CAgonist KOPC20010 by Gas-Chromatography/Mass Spectrometry and its Bioavailability in Sprague-Dawley Rats

Hye-Yeon Im, Ae-Nim Pae, Ha-Yun Yang, et al.
Journal of Pharmaceutical Investigation 41 (1) 31 (2011)
DOI: 10.4333/KPS.2011.41.1.031
Voir cet article

Fine-tuning serotonin2c receptor function in the brain: Molecular and functional implications

Kelly A. Berg, William P. Clarke, Kathryn A. Cunningham and Umberto Spampinato
Neuropharmacology 55 (6) 969 (2008)
DOI: 10.1016/j.neuropharm.2008.06.014
Voir cet article

Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors

Giorgio Racagni, Marco Andrea Riva, Raffaella Molteni, et al.
The World Journal of Biological Psychiatry 12 (8) 574 (2011)
DOI: 10.3109/15622975.2011.595823
Voir cet article

Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology

P. De Deurwaerdère, M. Lagière, M. Bosc and S. Navailles
Experimental Brain Research 230 (4) 477 (2013)
DOI: 10.1007/s00221-013-3508-2
Voir cet article

Drug discovery targeting human 5-HT2C receptors: Residues S3.36 and Y7.43 impact ligand—Binding pocket structure via hydrogen bond formation

Clinton E. Canal, Tania C. Cordova-Sintjago, Nancy Y. Villa, Li-Juan Fang and Raymond G. Booth
European Journal of Pharmacology 673 (1-3) 1 (2011)
DOI: 10.1016/j.ejphar.2011.10.006
Voir cet article

Serotonin Receptor 2C -759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients

Chi-Un Pae
Psychiatry Investigation 11 (3) 342 (2014)
DOI: 10.4306/pi.2014.11.3.342
Voir cet article

Controversies on the role of 5-HT2C receptors in the mechanisms of action of antidepressant drugs

Cedric B.P. Martin, Michel Hamon, Laurence Lanfumey and Raymond Mongeau
Neuroscience & Biobehavioral Reviews 42 208 (2014)
DOI: 10.1016/j.neubiorev.2014.03.001
Voir cet article

Anti-obesity pharmacotherapy: Future perspectives utilising 5-HT2C receptor agonists

Alice C. Dutton and Nicholas M. Barnes
Drug Discovery Today: Therapeutic Strategies 3 (4) 577 (2006)
DOI: 10.1016/j.ddstr.2006.11.005
Voir cet article

Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens

Gian Marco Leggio, Adeline Cathala, Delphine Moison, et al.
Neuropharmacology 56 (2) 507 (2009)
DOI: 10.1016/j.neuropharm.2008.10.005
Voir cet article

Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists

Faisal Hayat, Ambily Nath Indu Viswanath, Ae Nim Pae, et al.
Bioorganic & Medicinal Chemistry 23 (6) 1313 (2015)
DOI: 10.1016/j.bmc.2015.01.032
Voir cet article

Upregulation of 5-HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: Antagonism by Bacopa monnieri

Amee Krishnakumar, M.S. Nandhu and C.S. Paulose
Epilepsy & Behavior 16 (2) 225 (2009)
DOI: 10.1016/j.yebeh.2009.07.031
Voir cet article

Determination of 5-HT2Cagonist KKHQ80114 and KKHQ80109 in Rat Plasma and Urine by Gas-Chromatography/Mass Spectrometry

Hye-Yeon Im, Hye-Sil Park, Hyun-Ah Choo, Ae-Nim Pae and Oh-Seung Kwon
Journal of Korean Pharmaceutical Sciences 39 (5) 321 (2009)
DOI: 10.4333/KPS.2009.39.5.32
Voir cet article

Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects

Christiana Villela de Andrade Strauss, Maria Adrielle Vicente and Helio Zangrossi
Behavioural Brain Research 246 103 (2013)
DOI: 10.1016/j.bbr.2013.03.005
Voir cet article

Pharmacokinetics and Bioavailability of New Synthetic 5-HT2CAgonists, KKHQ80109 and KKHQ80114, in Sprague-Dawley Rats

Hye-Yeon Im, Hyun-Ah Choo, Ae-Nim Pae and Oh-Seung Kwon
Journal of Korean Pharmaceutical Sciences 39 (5) 327 (2009)
DOI: 10.4333/KPS.2009.39.5.327
Voir cet article

Systematic review, structural analysis, and new theoretical perspectives on the role of serotonin and associated genes in the etiology of psychopathy and sociopathy

Bariş O. Yildirim and Jan J.L. Derksen
Neuroscience & Biobehavioral Reviews 37 (7) 1254 (2013)
DOI: 10.1016/j.neubiorev.2013.04.009
Voir cet article

Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain

Ramez Ghanbari, Mostafa El Mansari and Pierre Blier
European Neuropsychopharmacology 22 (7) 518 (2012)
DOI: 10.1016/j.euroneuro.2011.11.005
Voir cet article

Serotoninergic agonists and antagonists are the modulators of α1-Adrenoceptor activity in rat brain cortical membranes

L. A. Nesterova and B. N. Manukhin
Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 7 (1) 45 (2013)
DOI: 10.1134/S1990747812030154
Voir cet article

Serotonin receptor signaling and regulation via β-arrestins

Laura M. Bohn and Cullen L. Schmid
Critical Reviews in Biochemistry and Molecular Biology 45 (6) 555 (2010)
DOI: 10.3109/10409238.2010.516741
Voir cet article

Region- and phase-dependent effects of 5-HT1A and 5-HT2C receptor activation on adult neurogenesis

Amélie Soumier, Mounira Banasr, Lydia Kerkerian-Le Goff and Annie Daszuta
European Neuropsychopharmacology 20 (5) 336 (2010)
DOI: 10.1016/j.euroneuro.2009.11.007
Voir cet article

Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model

Clinton E. Canal, Raymond G. Booth and Drake Morgan
Neuropharmacology 70 112 (2013)
DOI: 10.1016/j.neuropharm.2013.01.007
Voir cet article

Pharmacological and genetic interventions in serotonin (5-HT)2C receptors to alter drug abuse and dependence processes

Małgorzata Filip, Umberto Spampinato, Andrew C. McCreary and Edmund Przegaliński
Brain Research 1476 132 (2012)
DOI: 10.1016/j.brainres.2012.03.035
Voir cet article

Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors

Cedric Mombereau, Yukio Kawahara, Brigitta B. Gundersen, Kazuko Nishikura and Julie A. Blendy
Neuropharmacology 59 (6) 468 (2010)
DOI: 10.1016/j.neuropharm.2010.06.009
Voir cet article

Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze

Juliana O.G. Nascimento, Letícia Sumiko Kikuchi, Valquíria Camin de Bortoli, Hélio Zangrossi and Milena B. Viana
Brain Research Bulletin 109 39 (2014)
DOI: 10.1016/j.brainresbull.2014.09.011
Voir cet article

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors

V.J. Aloyo, K.A. Berg, U. Spampinato, W.P. Clarke and J.A. Harvey
Pharmacology & Therapeutics 121 (2) 160 (2009)
DOI: 10.1016/j.pharmthera.2008.10.010
Voir cet article

Serotonin in anxiety and panic: Contributions of the elevated T-maze

Hélio Zangrossi and Frederico G. Graeff
Neuroscience & Biobehavioral Reviews 46 397 (2014)
DOI: 10.1016/j.neubiorev.2014.03.007
Voir cet article

Cloning and expression of a zebrafish 5-HT2C receptor gene

Henning Schneider, Luke Fritzky, Jesse Williams, et al.
Gene 502 (2) 108 (2012)
DOI: 10.1016/j.gene.2012.03.070
Voir cet article

The effects of the selective 5-HT2C receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats

Paul V. Strong, Benjamin N. Greenwood and Monika Fleshner
Psychopharmacology 203 (4) 665 (2009)
DOI: 10.1007/s00213-008-1413-3
Voir cet article

Could agomelatine be the ideal antidepressant?

SR Pandi-Perumal, Venkatramanujan Srinivasan, PD Cardinali and MJ Monti
Expert Review of Neurotherapeutics 6 (11) 1595 (2006)
DOI: 10.1586/14737175.6.11.1595
Voir cet article

Eag 1, Eag 2 and Kcnn3 gene brain expression of isolated reared rats

S. Martin, C. Lino-de-Oliveira, S. R. L. Joca, et al.
Genes, Brain and Behavior 9 (8) 918 (2010)
DOI: 10.1111/j.1601-183X.2010.00632.x
Voir cet article

Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists

Roberta Galeazzi, Luca Massaccesi, Francesco Piva, Giovanni Principato and Emilioano Laudadio
Journal of Molecular Modeling 20 (3) (2014)
DOI: 10.1007/s00894-014-2120-0
Voir cet article

5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior

P.V. Strong, J.P. Christianson, A.B. Loughridge, et al.
Neuroscience 197 132 (2011)
DOI: 10.1016/j.neuroscience.2011.09.041
Voir cet article

An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function

Kevin C.F. Fone
Neuropharmacology 55 (6) 1015 (2008)
DOI: 10.1016/j.neuropharm.2008.06.061
Voir cet article

Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration

Maria Adrielle Vicente and Helio Zangrossi
The International Journal of Neuropsychopharmacology 15 (03) 389 (2012)
DOI: 10.1017/S1461145711000873
Voir cet article

A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment

Jose M. Palacios, Angel Pazos and Daniel Hoyer
Psychopharmacology 234 (9-10) 1395 (2017)
DOI: 10.1007/s00213-017-4545-5
Voir cet article

Back to the future of psychopharmacology: A perspective on animal models in drug discovery

Hendrikus Hendriksen and Lucianne Groenink
European Journal of Pharmacology 759 30 (2015)
DOI: 10.1016/j.ejphar.2015.03.020
Voir cet article

Membrane Proteins as Drug Targets

Vincent J. Aloyo, Kelly A. Berg, William P. Clarke, Umberto Spampinato and John A. Harvey
Progress in Molecular Biology and Translational Science, Membrane Proteins as Drug Targets 91 1 (2010)
DOI: 10.1016/S1877-1173(10)91001-6
Voir cet article

Paeoveitols A–E from Paeonia veitchii

Wen-Juan Liang, Yun-Bao Ma, Chang-An Geng, et al.
Fitoterapia 106 36 (2015)
DOI: 10.1016/j.fitote.2015.07.015
Voir cet article

Depression- and anxiogenic-like behaviors induced by lipopolysaccharide in mice are reversed by a selenium-containing indolyl compound: Behavioral, neurochemical and computational insights involving the serotonergic system

Angela Maria Casaril, Micaela Domingues, Darling de Andrade Lourenço, et al.
Journal of Psychiatric Research 115 1 (2019)
DOI: 10.1016/j.jpsychires.2019.05.006
Voir cet article

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with α/β-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors

Mark J. Millan and Anne Dekeyne
The International Journal of Neuropsychopharmacology 10 (05) (2007)
DOI: 10.1017/S1461145706007309
Voir cet article

Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice

Fabiana K. Ludka, Leandra Celso Constantino, Gislaine Kuminek, et al.
Pharmacology Biochemistry and Behavior 122 253 (2014)
DOI: 10.1016/j.pbb.2014.04.005
Voir cet article

L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson’s disease

K.L. Eskow Jaunarajs, J.A. George and C. Bishop
Neuroscience 218 243 (2012)
DOI: 10.1016/j.neuroscience.2012.05.052
Voir cet article

Diverse effects of 5-HT2C receptor blocking agents on c-Fos expression in the rat basal ganglia

Nabila Kadiri, Mélanie Lagière, Catherine Le Moine, et al.
European Journal of Pharmacology 689 (1-3) 8 (2012)
DOI: 10.1016/j.ejphar.2012.05.022
Voir cet article

Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders

Mark J. Millan, Guy M. Goodwin, Andreas Meyer-Lindenberg and Sven Ove Ögren
European Neuropsychopharmacology 25 (5) 599 (2015)
DOI: 10.1016/j.euroneuro.2015.01.016
Voir cet article

How serotonin receptors regulate morphogenic signalling in neurons

Alexander Wirth, Katrin Holst and Evgeni Ponimaskin
Progress in Neurobiology 151 35 (2017)
DOI: 10.1016/j.pneurobio.2016.03.007
Voir cet article

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

Philippe De Deurwaerdère and Giuseppe Di Giovanni
Progress in Neurobiology 151 175 (2017)
DOI: 10.1016/j.pneurobio.2016.03.004
Voir cet article

Gq/5-HT2c receptor signals activate a local GABAergic inhibitory feedback circuit to modulate serotonergic firing and anxiety in mice

K. Spoida, O. A. Masseck, E. S. Deneris and S. Herlitze
Proceedings of the National Academy of Sciences 111 (17) 6479 (2014)
DOI: 10.1073/pnas.1321576111
Voir cet article

Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin–Pinoline Hybrids

Mario de la Fuente Revenga, Concepción Pérez, José A. Morales-García, et al.
ACS Chemical Neuroscience 6 (5) 800 (2015)
DOI: 10.1021/acschemneuro.5b00041
Voir cet article

Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex

C. Nocjar, K.D. Alex, A. Sonneborn, et al.
Neuroscience 297 22 (2015)
DOI: 10.1016/j.neuroscience.2015.03.050
Voir cet article

Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopram

Robert L. Gannon, Jean-Louis Peglion and Mark J. Millan
European Neuropsychopharmacology 19 (12) 887 (2009)
DOI: 10.1016/j.euroneuro.2009.06.011
Voir cet article

Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?

M. Hamon and S. Bourgoin
European Neuropsychopharmacology 16 S625 (2006)
DOI: 10.1016/S0924-977X(06)70008-6
Voir cet article

Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture

Amandine Descamps, Colette Rousset, Mark Millan, et al.
Psychopharmacology 205 (1) 93 (2009)
DOI: 10.1007/s00213-009-1519-2
Voir cet article

Agomelatina: un nuevo enfoque farmacológico en el tratamiento de la depresión con traducción clínica

Cecilio Álamo, Francisco López-Muñoz and María José Armada
Psiquiatría Biológica 15 (4) 125 (2008)
DOI: 10.1016/S1134-5934(08)76482-0
Voir cet article

New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders

Giuseppe Di Giovanni and Philippe De Deurwaerdère
Pharmacology & Therapeutics 157 125 (2016)
DOI: 10.1016/j.pharmthera.2015.11.009
Voir cet article

Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow

Céline Devroye, Adeline Cathala, Marlène Maitre, et al.
Neuropharmacology 89 375 (2015)
DOI: 10.1016/j.neuropharm.2014.10.016
Voir cet article

Robust optimization of SVM hyperparameters in the classification of bioactive compounds

Wojciech M Czarnecki, Sabina Podlewska and Andrzej J Bojarski
Journal of Cheminformatics 7 (1) (2015)
DOI: 10.1186/s13321-015-0088-0
Voir cet article

Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment

Maria Adrielle Vicente and Helio Zangrossi
Neuropharmacology 79 127 (2014)
DOI: 10.1016/j.neuropharm.2013.11.007
Voir cet article

Exploiting uncertainty measures in compounds activity prediction using support vector machines

Sabina Smusz, Wojciech Marian Czarnecki, Dawid Warszycki and Andrzej J. Bojarski
Bioorganic & Medicinal Chemistry Letters 25 (1) 100 (2015)
DOI: 10.1016/j.bmcl.2014.11.005
Voir cet article

Effect of the 5-HT2C Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study

Sara Whitestone, Philippe De Deurwaerdère, Lynn Baassiri, et al.
International Journal of Molecular Sciences 20 (12) 2925 (2019)
DOI: 10.3390/ijms20122925
Voir cet article

(±)-Paeoveitol, a Pair of New Norditerpene Enantiomers from Paeonia veitchii

Wen-Juan Liang, Chang-An Geng, Xue-Mei Zhang, Hao Chen, Cai-Yan Yang, Guang-Qing Rong, Yong Zhao, Hong-Bo Xu, Hao Wang, Ning-Jia Zhou, Yun-Bao Ma, Xiao-Yan Huang and Ji-Jun Chen
Organic Letters 16 (2) 424 (2014)
DOI: 10.1021/ol403315d
Voir cet article

Role of G Protein-Coupled Receptors in the Regulation of Structural Plasticity and Cognitive Function

Crystal Leung and Yung Wong
Molecules 22 (7) 1239 (2017)
DOI: 10.3390/molecules22071239
Voir cet article

Structure–activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity

Agnieszka Zagórska, Marcin Kołaczkowski, Adam Bucki, et al.
European Journal of Medicinal Chemistry 97 142 (2015)
DOI: 10.1016/j.ejmech.2015.04.046
Voir cet article

Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases

Thi Thanh Binh Nguyen, Yan Yan Jin, Hea-Jong Chung and Seong-Tschool Hong
Molecules 22 (10) 1795 (2017)
DOI: 10.3390/molecules22101795
Voir cet article

Endogenous 5-HT2C Receptors Phosphorylate the cAMP Response Element Binding Protein via Protein Kinase C-Promoted Activation of Extracellular-Regulated Kinases-1/2 in Hypothalamic mHypoA-2/10 Cells

L. Lauffer, E. Glas, T. Gudermann and A. Breit
Journal of Pharmacology and Experimental Therapeutics 358 (1) 39 (2016)
DOI: 10.1124/jpet.116.232397
Voir cet article

New insight into the therapeutic role of the serotonergic system in Parkinson's disease

Yukihiro Ohno, Saki Shimizu, Kentaro Tokudome, Naofumi Kunisawa and Masashi Sasa
Progress in Neurobiology 134 104 (2015)
DOI: 10.1016/j.pneurobio.2015.09.005
Voir cet article

Modulation of Monoamine Receptors by Adaptor Proteins and Lipid Rafts: Role in Some Effects of Centrally Acting Drugs and Therapeutic Agents

Karl Björk and Per Svenningsson
Annual Review of Pharmacology and Toxicology 51 (1) 211 (2011)
DOI: 10.1146/annurev-pharmtox-010510-100520
Voir cet article

Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: A comparison to melatonin and to the 5-HT2c antagonist, S32006

Trevor R. Norman, Ingrid Cranston, Jeremy A. Irons, et al.
European Journal of Pharmacology 674 (1) 27 (2012)
DOI: 10.1016/j.ejphar.2011.10.010
Voir cet article

Circuits Regulating Pleasure and Happiness—Mechanisms of Depression

Anton J. M. Loonen and Svetlana A. Ivanova
Frontiers in Human Neuroscience 10 (2016)
DOI: 10.3389/fnhum.2016.00571
Voir cet article

Physical Interaction of Calmodulin with the 5-Hydroxytryptamine2C Receptor C-Terminus Is Essential for G Protein-independent, Arrestin-dependent Receptor Signaling

Marilyne Labasque, Eric Reiter, Carine Becamel, et al.
Molecular Biology of the Cell 19 (11) 4640 (2008)
DOI: 10.1091/mbc.e08-04-0422
Voir cet article

Multiscale neurobiological correlates of human neuroticism

Qiang Xu, Feng Liu, Wen Qin, Tianzi Jiang and Chunshui Yu
Human Brain Mapping (2020)
DOI: 10.1002/hbm.25153
Voir cet article

The role of the AMPA receptor and 5-HT3 receptor on aggressive behavior and depressive-like symptoms in chronic social isolation-reared mice

Koh Shimizu, Natsuki Kurosawa and Kenjiro Seki
Physiology & Behavior 153 70 (2016)
DOI: 10.1016/j.physbeh.2015.10.026
Voir cet article

Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction

David M Thomson, Emma J Mitchell, Rebecca L Openshaw, Judith A Pratt and Brian J Morris
Journal of Psychopharmacology 35 (10) 1265 (2021)
DOI: 10.1177/02698811211032439
Voir cet article

Conséquences de l’inter-relation des systèmes monoaminergiques dans l’activité antidépressive

L. Tritschler, R. Gaillard, A.M. Gardier, D.J. David and J.-P. Guilloux
L'Encéphale 44 (3) 264 (2018)
DOI: 10.1016/j.encep.2018.05.001
Voir cet article

The role of dopamine in overcoming aversion with exercise

Benjamin N. Greenwood
Brain Research 1713 102 (2019)
DOI: 10.1016/j.brainres.2018.08.030
Voir cet article

Association between serotonin 2C receptor gene (HTR2C) polymorphisms and psychopathological symptoms in children and adolescents

L.A. Paes, O.H. Della Torre, T.B. Henriques, et al.
Brazilian Journal of Medical and Biological Research 51 (8) (2018)
DOI: 10.1590/1414-431x20187252
Voir cet article

Altered serotonin 2C receptor RNA splicing in suicide: association with editing

Stella Dracheva, Benjamin Chin and Vahram Haroutunian
NeuroReport 19 (3) 379 (2008)
DOI: 10.1097/WNR.0b013e3282f556d2
Voir cet article

Norfluoxetine and venlafaxine in zebrafish larvae: Single and combined toxicity of two pharmaceutical products relevant for risk assessment

P. Rodrigues, V. Cunha, L. Oliva-Teles, M. Ferreira and L. Guimarães
Journal of Hazardous Materials 400 123171 (2020)
DOI: 10.1016/j.jhazmat.2020.123171
Voir cet article

Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents

Agnieszka Zagórska, Adam Bucki, Marcin Kołaczkowski, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry 31 (sup3) 10 (2016)
DOI: 10.1080/14756366.2016.1198902
Voir cet article

Circuits regulating pleasure and happiness in major depression

A.J.M. Loonen and S.A. Ivanova
Medical Hypotheses 87 14 (2016)
DOI: 10.1016/j.mehy.2015.12.013
Voir cet article

Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138

Mark J. Millan and Mauricette Brocco
Thérapie 63 (3) 187 (2008)
DOI: 10.2515/therapie:2008041
Voir cet article

S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: I. A Mechanistic Characterization

Mark J. Millan, Clotilde Mannoury la Cour, Benjamin Chanrion, et al.
Journal of Pharmacology and Experimental Therapeutics 340 (3) 750 (2012)
DOI: 10.1124/jpet.111.187468
Voir cet article

S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: II. A Behavioral, Neurochemical, and Electrophysiological Characterization

Anne Dekeyne, Mauricette Brocco, Florence Loiseau, et al.
Journal of Pharmacology and Experimental Therapeutics 340 (3) 765 (2012)
DOI: 10.1124/jpet.111.187534
Voir cet article

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

William J. Thomsen, Andrew J. Grottick, Frederique Menzaghi, et al.
Journal of Pharmacology and Experimental Therapeutics 325 (2) 577 (2008)
DOI: 10.1124/jpet.107.133348
Voir cet article

Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants

Marilyne Labasque, Julie Meffre, Gaelle Carrat, et al.
Molecular Pharmacology 78 (5) 818 (2010)
DOI: 10.1124/mol.110.066035
Voir cet article

Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell Surface Expression and Signal Transduction

Benjamin Chanrion, Clotilde Mannoury la Cour, Sophie Gavarini, et al.
Molecular Pharmacology 73 (3) 748 (2008)
DOI: 10.1124/mol.107.041574
Voir cet article

Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity

Darya V. Bazovkina, Elena M. Kondaurova, Vladimir S. Naumenko and Evgeni Ponimaskin
Neural Plasticity 2015 1 (2015)
DOI: 10.1155/2015/846589
Voir cet article

Encyclopedia of Signaling Molecules

Carine Bécamel, Philippe Marin and Joël Bockaert
Encyclopedia of Signaling Molecules 24 (2018)
DOI: 10.1007/978-3-319-67199-4_55
Voir cet article

Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures

Marcello Venzi, François David, Joachim Bellet, et al.
Neuropharmacology 108 292 (2016)
DOI: 10.1016/j.neuropharm.2016.04.016
Voir cet article

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

Giuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, et al.
Frontiers in Neuroscience 10 (2016)
DOI: 10.3389/fnins.2016.00541
Voir cet article

Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence

Francis Delicata, Cristiano Bombardi, Massimo Pierucci, et al.
CNS Neuroscience & Therapeutics 24 (8) 721 (2018)
DOI: 10.1111/cns.12830
Voir cet article

Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors

Pia Weikop, Jan Kehr and Jørgen Scheel-Krüger
Journal of Psychopharmacology 21 (8) 795 (2007)
DOI: 10.1177/0269881107077347
Voir cet article

Envolvimento de receptores 5-HT2C do hipocampo ventral em comportamentos de defesa de ratos no labirinto em cruz elevado

Marília Greidinger Carvalho, Graziela Furtado Scarpelli Ferreira, Marcelo de Faria Salviano, et al.
Estudos de Psicologia (Natal) 17 (1) 145 (2012)
DOI: 10.1590/S1413-294X2012000100018
Voir cet article

The Immune System and Mental Health

The Immune System and Mental Health 555 (2018)
DOI: 10.1016/B978-0-12-811351-6.00026-7
Voir cet article

A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide

Antonio Fabio Di Narzo, Alexey Kozlenkov, Panos Roussos, et al.
Human Molecular Genetics 23 (18) 4801 (2014)
DOI: 10.1093/hmg/ddu195
Voir cet article

The effects of pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in mice

Matthew R. Bailey, Cait Williamson, Chris Mezias, et al.
Psychopharmacology 233 (4) 615 (2016)
DOI: 10.1007/s00213-015-4135-3
Voir cet article

Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties

Anders A. Jensen, Niels Plath, Martin H. F. Pedersen, Vignir Isberg, Jacob Krall, Petrine Wellendorph, Tine B. Stensbøl, David E. Gloriam, Povl Krogsgaard-Larsen and Bente Frølund
Journal of Medicinal Chemistry 56 (3) 1211 (2013)
DOI: 10.1021/jm301656h
Voir cet article

The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania

Frank I Tarazi and Jo C Neill
Expert Opinion on Drug Discovery 8 (1) 93 (2013)
DOI: 10.1517/17460441.2013.738193
Voir cet article

Investigational melatonin receptor agonists

Rüdiger Hardeland
Expert Opinion on Investigational Drugs 19 (6) 747 (2010)
DOI: 10.1517/13543784.2010.482926
Voir cet article

Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects

Vanja Duric, Mounira Banasr, Craig A. Stockmeier, et al.
International Journal of Neuropsychopharmacology 16 (1) 69 (2013)
DOI: 10.1017/S1461145712000016
Voir cet article

Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease

Sylvia Navailles, Mélanie Lagière, Audrey Roumegous, et al.
International Journal of Neuropsychopharmacology 16 (3) 593 (2013)
DOI: 10.1017/S1461145712000417
Voir cet article

Creating the New from the Old: Combinatorial Libraries Generation with Machine-Learning-Based Compound Structure Optimization

Sabina Podlewska, Wojciech M. Czarnecki, Rafał Kafel and Andrzej J. Bojarski
Journal of Chemical Information and Modeling 57 (2) 133 (2017)
DOI: 10.1021/acs.jcim.6b00426
Voir cet article

Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats

Ana Beatriz Sant’Ana, Heloisa Helena Vilela-Costa, Maria Adrielle Vicente, et al.
Neuropharmacology 148 311 (2019)
DOI: 10.1016/j.neuropharm.2019.01.026
Voir cet article

5-HT Receptors and the Development of New Antidepressants

Grzegorz Ślifirski, Marek Król and Jadwiga Turło
International Journal of Molecular Sciences 22 (16) 9015 (2021)
DOI: 10.3390/ijms22169015
Voir cet article

Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism

Stephen M. Stahl
The International Journal of Neuropsychopharmacology 10 (05) (2007)
DOI: 10.1017/S1461145707008000
Voir cet article

Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms

Robert L. Gannon and Mark J. Millan
Psychopharmacology 195 (3) 325 (2007)
DOI: 10.1007/s00213-007-0903-z
Voir cet article

Role of the Melatonin System in the Control of Sleep

Seithikurippu R Pandi-Perumal, Venkatramanujan Srinivasan, D Warren Spence and Daniel P Cardinali
CNS Drugs 21 (12) 995 (2007)
DOI: 10.2165/00023210-200721120-00004
Voir cet article

The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits

A. M. Allan, X. Liang, Y. Luo, et al.
Human Molecular Genetics 17 (13) 2047 (2008)
DOI: 10.1093/hmg/ddn102
Voir cet article

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

Anne Dekeyne, Clotilde Mannoury la Cour, Alain Gobert, et al.
Psychopharmacology 199 (4) 549 (2008)
DOI: 10.1007/s00213-008-1177-9
Voir cet article

Discriminative stimulus properties of the “atypical” antidepressant, mirtazapine, in rats: a pharmacological characterization

Anne Dekeyne and Mark J. Millan
Psychopharmacology 203 (2) 329 (2009)
DOI: 10.1007/s00213-008-1259-8
Voir cet article

RNA editing of the serotonin 2C receptor and expression of Gαqprotein: genetic mouse models do not support a role for regulation or compensation

Clinton E. Canal, Kontip C. Mahautmr, Chike Cao, Elaine Sanders-Bush and David C. Airey
Journal of Neurochemistry 108 (5) 1136 (2009)
DOI: 10.1111/j.1471-4159.2008.05852.x
Voir cet article

A Potential PET Radiotracer for the 5-HT2C Receptor: Synthesis and in Vivo Evaluation of 4-(3-[18F]fluorophenethoxy)pyrimidine

Juhyeon Kim, Byung Seok Moon, Byung Chul Lee, Ho-Young Lee, Hak-Joong Kim, Hyunah Choo, Ae Nim Pae, Yong Seo Cho and Sun-Joon Min
ACS Chemical Neuroscience 8 (5) 996 (2017)
DOI: 10.1021/acschemneuro.6b00445
Voir cet article

Overexpression of 5-HT2Creceptors in forebrain leads to elevated anxiety and hypoactivity

Atsuko Kimura, Paula L. Stevenson, Roderick N. Carter, et al.
European Journal of Neuroscience 30 (2) 299 (2009)
DOI: 10.1111/j.1460-9568.2009.06831.x
Voir cet article

In vivoevidence that constitutive activity of serotonin2Creceptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist

Gian Marco Leggio, Adeline Cathala, Maud Neny, et al.
Journal of Neurochemistry 111 (2) 614 (2009)
DOI: 10.1111/j.1471-4159.2009.06356.x
Voir cet article

Handbook of Neuroscience for the Behavioral Sciences

Gary L. Wenk and Yannick Marchalant
Handbook of Neuroscience for the Behavioral Sciences (2009)
DOI: 10.1002/9780470478509.neubb001006
Voir cet article

Differential effects of acute and repeated citalopram in mouse models of anxiety and depression

Cedric Mombereau, Tamar L. Gur, Jennifer Onksen and Julie A. Blendy
The International Journal of Neuropsychopharmacology 13 (03) 321 (2010)
DOI: 10.1017/S1461145709990630
Voir cet article

The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen

Clinton E. Canal, Uade B. Olaghere da Silva, Paul J. Gresch, et al.
Psychopharmacology 209 (2) 163 (2010)
DOI: 10.1007/s00213-010-1784-0
Voir cet article

The pharmacological properties of antidepressants

Giorgio Racagni and Maurizio Popoli
International Clinical Psychopharmacology 25 (3) 117 (2010)
DOI: 10.1097/YIC.0b013e3283311acd
Voir cet article

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

Christian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, et al.
Nature Reviews Drug Discovery 9 (8) 628 (2010)
DOI: 10.1038/nrd3140
Voir cet article

An immunocapture/scintillation proximity analysis of Gαq/11 activation by native serotonin (5-HT)2A receptors in rat cortex: Blockade by clozapine and mirtazapine

C. Mannoury La Cour, C. Chaput, M. Touzard and M.J. Millan
Synapse 63 (2) 95 (2008)
DOI: 10.1002/syn.20587
Voir cet article

No link of serotonin 2C receptor editing to serotonin transporter genotype

Rebecca Lyddon, Edwin Cuppen, Vahram Haroutunian, Larry J. Siever and Stella Dracheva
NeuroReport 21 (17) 1080 (2010)
DOI: 10.1097/WNR.0b013e32834052f0
Voir cet article

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice

Vincent Martin, Najib Allaïli, Marine Euvrard, et al.
Scientific Reports 7 (1) 45907 (2017)
DOI: 10.1038/srep45907
Voir cet article

The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites

Elena K. Schneider, Rachel M. McQuade, Vincenzo C. Carbone, et al.
ERJ Open Research 4 (1) 00127-2017 (2018)
DOI: 10.1183/23120541.00127-2017
Voir cet article

Behavioral Neurobiology of Anxiety and Its Treatment

C. Durant, D. Christmas and D. Nutt
Current Topics in Behavioral Neurosciences, Behavioral Neurobiology of Anxiety and Its Treatment 2 303 (2009)
DOI: 10.1007/7854_2009_8
Voir cet article

5-HT2C Receptors in the Pathophysiology of CNS Disease

Maria N. Garnovskaya and John R. Raymond
5-HT2C Receptors in the Pathophysiology of CNS Disease 75 (2011)
DOI: 10.1007/978-1-60761-941-3_5
Voir cet article

5-HT2C Receptors in the Pathophysiology of CNS Disease

Annie Daszuta
The Receptors, 5-HT2C Receptors in the Pathophysiology of CNS Disease 22 169 (2011)
DOI: 10.1007/978-1-60761-941-3_9
Voir cet article

Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine

Takahide Shuto, Mahomi Kuroiwa, Naoki Sotogaku, et al.
Molecular Psychiatry 25 (6) 1229 (2020)
DOI: 10.1038/s41380-018-0316-x
Voir cet article

Behavioural Models for the Characterisation of Established and Innovative Antidepressant Agents

Anne Dekeyne
Therapies 60 (5) 477 (2005)
DOI: 10.2515/therapie:2005068
Voir cet article

Asenapine reduces anxiety-related behaviours in rat conditioned fear stress model

Masayo Ohyama, Maho Kondo, Miki Yamauchi, Taiichiro Imanishi and Tsukasa Koyama
Acta Neuropsychiatrica 28 (6) 327 (2016)
DOI: 10.1017/neu.2016.17
Voir cet article

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Mark J. Millan
Pharmacology & Therapeutics 110 (2) 135 (2006)
DOI: 10.1016/j.pharmthera.2005.11.006
Voir cet article

Opposing Roles for 5-HT2A and 5-HT2C Receptors in the Nucleus Accumbens on Inhibitory Response Control in the 5-Choice Serial Reaction Time Task

Emma S J Robinson, Jeffrey W Dalley, David E H Theobald, et al.
Neuropsychopharmacology 33 (10) 2398 (2008)
DOI: 10.1038/sj.npp.1301636
Voir cet article

Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus

Amélie Soumier, Mounira Banasr, Sylviane Lortet, et al.
Neuropsychopharmacology 34 (11) 2390 (2009)
DOI: 10.1038/npp.2009.72
Voir cet article

CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling

Ana C Magalhaes, Kevin D Holmes, Lianne B Dale, et al.
Nature Neuroscience 13 (5) 622 (2010)
DOI: 10.1038/nn.2529
Voir cet article

Mechanism of Action of Trazodone: a Multifunctional Drug

Stephen M. Stahl
CNS Spectrums 14 (10) 536 (2009)
DOI: 10.1017/S1092852900024020
Voir cet article

Antidepressant and anxiolytic efficacy of single, chronic and concomitant use of vortioxetine, dapoxetine and fluoxetine in prenatally stressed rats

Piotr Ratajczak, Krzysztof Kus, Tomasz Zaprutko, et al.
Acta Neurobiologiae Experimentalis 79 (1) 13 (2019)
DOI: 10.21307/ane-2019-002
Voir cet article

Encyclopedia of Signaling Molecules

Carine Bécamel, Philippe Marin and Joël Bockaert
Encyclopedia of Signaling Molecules 1 (2017)
DOI: 10.1007/978-1-4614-6438-9_55-1
Voir cet article

Decoding the similarities and specific differences between latent and active tuberculosis infections based on consistently differential expression networks

Jun Sun, Qianqian Shi, Xi Chen and Rong Liu
Briefings in Bioinformatics 21 (6) 2084 (2020)
DOI: 10.1093/bib/bbz127
Voir cet article

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Alexandre V. Ivachtchenko, Yan Lavrovsky and Ilya Okun
Journal of Alzheimer's Disease 53 (2) 583 (2016)
DOI: 10.3233/JAD-151146
Voir cet article

Mirtazapine attenuates anxiety- and depression-like behaviors in rats during cocaine withdrawal

Susana Barbosa Méndez and Alberto Salazar-Juárez
Journal of Psychopharmacology 33 (5) 589 (2019)
DOI: 10.1177/0269881119840521
Voir cet article

The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders

Mark J Millan, Jean-Michel Rivet and Alain Gobert
Journal of Psychopharmacology 30 (11) 1099 (2016)
DOI: 10.1177/0269881116672342
Voir cet article

Constitutive activity of 5-HT receptors: Factual analysis

Philippe De Deurwaerdère, Rahul Bharatiya, Abdeslam Chagraoui and Giuseppe Di Giovanni
Neuropharmacology 168 107967 (2020)
DOI: 10.1016/j.neuropharm.2020.107967
Voir cet article

Handbook of the Behavioral Neurobiology of Serotonin

Hélio Zangrossi, Cristina Marta Del Ben, Frederico Guilherme Graeff and Francisco Silveira Guimarães
Handbook of Behavioral Neuroscience, Handbook of the Behavioral Neurobiology of Serotonin 31 611 (2020)
DOI: 10.1016/B978-0-444-64125-0.00036-0
Voir cet article

In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay

Ellen A. Walker, Edward K. Brown and Steven N. Sterious
Psychopharmacology 193 (2) 187 (2007)
DOI: 10.1007/s00213-007-0769-0
Voir cet article

Metabolic, Molecular, and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity?

Ekaterina Veniaminova, Raymond Cespuglio, Irina Chernukha, et al.
Frontiers in Neuroscience 14 (2020)
DOI: 10.3389/fnins.2020.00024
Voir cet article

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi and Michael Nader
Pharmacological Reviews 73 (1) 202 (2021)
DOI: 10.1124/pharmrev.120.000056
Voir cet article

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, et al.
Pharmacological Reviews 73 (1) 310 (2021)
DOI: 10.1124/pr.118.015552
Voir cet article

Serotonin in Animal Cognition and Behavior

Julien Bacqué-Cazenave, Rahul Bharatiya, Grégory Barrière, et al.
International Journal of Molecular Sciences 21 (5) 1649 (2020)
DOI: 10.3390/ijms21051649
Voir cet article

Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra

Mary V. Burke, Christine Nocjar, Alex J. Sonneborn, Andrew C. McCreary and Elizabeth A. Pehek
Journal of Neurochemistry 131 (4) 432 (2014)
DOI: 10.1111/jnc.12842
Voir cet article

Novel tricyclic[2,1-f]theophylline derivatives of LCAP with activity in mouse models of affective disorders

Anna Partyka, Jakub Jarosz, Anna Wasik, et al.
Journal of Pharmacy and Pharmacology 66 (12) 1755 (2014)
DOI: 10.1111/jphp.12305
Voir cet article

Insights into serotonergic and antioxidant mechanisms involved in antidepressant-like action of 2-phenyl-3-(phenylselanyl)benzofuran in mice

Jéssica Iara Gall, Amália Gonçalves Alves, Luiz Roberto Carraro Júnior, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry 102 109956 (2020)
DOI: 10.1016/j.pnpbp.2020.109956
Voir cet article

5-HT2C receptors in psychiatric disorders: A review

A. Chagraoui, F. Thibaut, M. Skiba, C. Thuillez and M. Bourin
Progress in Neuro-Psychopharmacology and Biological Psychiatry 66 120 (2016)
DOI: 10.1016/j.pnpbp.2015.12.006
Voir cet article

Use of second generation antipsychotics for treatment-resistant major depressive disorder

Rebecca Waite
Mental Health Clinician 4 (5) 246 (2014)
DOI: 10.9740/mhc.n207192
Voir cet article

The preclinical discovery and development of agomelatine for the treatment of depression

George Konstantakopoulos, Stefanos Dimitrakopoulos and Panayiota G. Michalopoulou
Expert Opinion on Drug Discovery 15 (10) 1121 (2020)
DOI: 10.1080/17460441.2020.1781087
Voir cet article

Effect of 5-HT2C receptor agonist and antagonist on chronic unpredictable stress (CUS) - Mediated anxiety and depression in adolescent Wistar albino rat: Implicating serotonin and mitochondrial ETC-I function in serotonergic neurotransmission

Wankupar Wankhar, Donkupar Syiem, Careen Liza Pakyntein, Daiahun Thabah and Shelareen Ediemi Sunn
Behavioural Brain Research 393 112780 (2020)
DOI: 10.1016/j.bbr.2020.112780
Voir cet article

5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B

Philippe De Deurwaerdère, Abdeslam Chagraoui and Giuseppe Di Giovanni
Progress in Brain Research, 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B 261 161 (2021)
DOI: 10.1016/bs.pbr.2021.02.001
Voir cet article

Acute Angle-Closure—A Rare but Vision-Threatening Ocular Adverse Effect of Selective Serotonin Reuptake Inhibitors

Michał Wiciński, Bartlomiej J. Kaluzny, Sławomir Liberski, Daria Marczak and Jakub J. Kaluzny
Applied Sciences 11 (7) 3140 (2021)
DOI: 10.3390/app11073140
Voir cet article

5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray

Paula Shimene de Melo Yamashita, Valquiria Camin de Bortoli and Helio Zangrossi
Neuropharmacology 60 (2-3) 216 (2011)
DOI: 10.1016/j.neuropharm.2010.09.001
Voir cet article

MicroRNA-34a regulates 5-HT2C expression in dorsal raphe and contributes to the anti-depressant-like effect of fluoxetine

Luisa Lo Iacono, Donald Ielpo, Chiara Parisi, et al.
Neuropharmacology 190 108559 (2021)
DOI: 10.1016/j.neuropharm.2021.108559
Voir cet article

Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug’s unique receptor profile: a case report

Verena Sichert and Hans-Peter Volz
Fortschritte der Neurologie · Psychiatrie 89 (04) 178 (2021)
DOI: 10.1055/a-1183-3887
Voir cet article

The combination of agomelatine and ritanserin exerts a synergistic interaction in passive avoidance task

F İlkaya, M Yüce, AE Ağrı, et al.
Human & Experimental Toxicology 34 (8) 787 (2015)
DOI: 10.1177/0960327114559613
Voir cet article

5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

Valquíria Camin de Bortoli, Paula Shimene de Melo Yamashita and Hélio Zangrossi
Journal of Psychopharmacology 27 (12) 1116 (2013)
DOI: 10.1177/0269881113492900
Voir cet article

Disfunzioni sessuali correlate al trattamento del disturbo depressivo maggiore con farmaci antidepressivi

Luigi Lombardo and Roberta Rossi
DOI: 10.3280/RSC2014-002003
Voir cet article

New medications for obesity management

Nadia Boulghassoul-Pietrzykowska, Jennifer Franceschelli and Christopher Still
Current Opinion in Endocrinology, Diabetes & Obesity 20 (5) 407 (2013)
DOI: 10.1097/
Voir cet article

GPCR Interacting Proteins (GIPs) in the Nervous System: Roles in Physiology and Pathologies

Joël Bockaert, Julie Perroy, Carine Bécamel, Philippe Marin and Laurent Fagni
Annual Review of Pharmacology and Toxicology 50 (1) 89 (2010)
DOI: 10.1146/annurev.pharmtox.010909.105705
Voir cet article